Cancer-related hypercalcemia

Research output: Contribution to journalReview article

31 Citations (Scopus)

Abstract

Hypercalcemia has been reported to occur in up to30%of patients whohave a malignancy. Hypercalcemia is most common in those who have later-stage malignancies and predicts a poor prognosis for those with it. The most common causes include humoral hypercalcemia of malignancy mediated by parathyroid hormone-related peptide, osteolytic cytokine production, and excess 1,25-dihydroxy vitaminDproduction. However, the etiology is not always mediated by malignancy. Hypercalcemia can occur in those with malignancy and an additional etiology for hypercalcemia such as primary hyperparathyroidism or granulomatous diseases. This paper reviews the cancers associated with hypercalcemia and their proposed mechanisms, nontumor-mediated hypercalcemia, as well as diagnosis and treatment strategies for each condition.

Original languageEnglish (US)
Pages (from-to)426-432
Number of pages7
JournalJournal of oncology practice
Volume12
Issue number5
DOIs
StatePublished - May 2016

Fingerprint

Hypercalcemia
Neoplasms
Parathyroid Hormone-Related Protein
Primary Hyperparathyroidism
Cytokines

ASJC Scopus subject areas

  • Oncology
  • Oncology(nursing)
  • Health Policy

Cite this

Cancer-related hypercalcemia. / Goldner, Whitney S.

In: Journal of oncology practice, Vol. 12, No. 5, 05.2016, p. 426-432.

Research output: Contribution to journalReview article

@article{3fc242d0188b4e67b0bd074997d53c7f,
title = "Cancer-related hypercalcemia",
abstract = "Hypercalcemia has been reported to occur in up to30{\%}of patients whohave a malignancy. Hypercalcemia is most common in those who have later-stage malignancies and predicts a poor prognosis for those with it. The most common causes include humoral hypercalcemia of malignancy mediated by parathyroid hormone-related peptide, osteolytic cytokine production, and excess 1,25-dihydroxy vitaminDproduction. However, the etiology is not always mediated by malignancy. Hypercalcemia can occur in those with malignancy and an additional etiology for hypercalcemia such as primary hyperparathyroidism or granulomatous diseases. This paper reviews the cancers associated with hypercalcemia and their proposed mechanisms, nontumor-mediated hypercalcemia, as well as diagnosis and treatment strategies for each condition.",
author = "Goldner, {Whitney S}",
year = "2016",
month = "5",
doi = "10.1200/JOP.2016.011155",
language = "English (US)",
volume = "12",
pages = "426--432",
journal = "Journal of Oncology Practice",
issn = "1554-7477",
publisher = "American Society of Clinical Oncology",
number = "5",

}

TY - JOUR

T1 - Cancer-related hypercalcemia

AU - Goldner, Whitney S

PY - 2016/5

Y1 - 2016/5

N2 - Hypercalcemia has been reported to occur in up to30%of patients whohave a malignancy. Hypercalcemia is most common in those who have later-stage malignancies and predicts a poor prognosis for those with it. The most common causes include humoral hypercalcemia of malignancy mediated by parathyroid hormone-related peptide, osteolytic cytokine production, and excess 1,25-dihydroxy vitaminDproduction. However, the etiology is not always mediated by malignancy. Hypercalcemia can occur in those with malignancy and an additional etiology for hypercalcemia such as primary hyperparathyroidism or granulomatous diseases. This paper reviews the cancers associated with hypercalcemia and their proposed mechanisms, nontumor-mediated hypercalcemia, as well as diagnosis and treatment strategies for each condition.

AB - Hypercalcemia has been reported to occur in up to30%of patients whohave a malignancy. Hypercalcemia is most common in those who have later-stage malignancies and predicts a poor prognosis for those with it. The most common causes include humoral hypercalcemia of malignancy mediated by parathyroid hormone-related peptide, osteolytic cytokine production, and excess 1,25-dihydroxy vitaminDproduction. However, the etiology is not always mediated by malignancy. Hypercalcemia can occur in those with malignancy and an additional etiology for hypercalcemia such as primary hyperparathyroidism or granulomatous diseases. This paper reviews the cancers associated with hypercalcemia and their proposed mechanisms, nontumor-mediated hypercalcemia, as well as diagnosis and treatment strategies for each condition.

UR - http://www.scopus.com/inward/record.url?scp=84969190341&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969190341&partnerID=8YFLogxK

U2 - 10.1200/JOP.2016.011155

DO - 10.1200/JOP.2016.011155

M3 - Review article

C2 - 27170690

AN - SCOPUS:84969190341

VL - 12

SP - 426

EP - 432

JO - Journal of Oncology Practice

JF - Journal of Oncology Practice

SN - 1554-7477

IS - 5

ER -